Evidence map›Paper›PMID 1654337›Full record

ArticleThe Journal of cell biology1991

Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan.

G Brunner, J Gabrilove, D B Rifkin, E L Wilson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 144 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2012
    Article
  6. Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2009
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Cytokines and proteoglycans.Experientia · 1993
    Review
  20. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells.Proceedings of the National Academy of Sciences of the United States of America · 1992
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

G BrunnerDepartment of Cell Biology, New York University Medical Center, New York 10016.
J Gabrilove
D B Rifkin
E L Wilson
Columbia University Irving Medical Center · USNew York University · US

Funding

Regulation of TGF-Beta Activity in the Lung by LTBP-4R01CA034282 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RIFKIN, DANIEL B · 1985 to 2016
$5.8M
HUMAN HEMATOPOIETIC TUMORS PROGRAM PROJECTP01CA020194 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI CLARKSON, BAYARD D · 1985 to 1992
–
THE ROLE OF PLASMINOGEN ACTIVATORS IN MYELOPOIESISR01CA049419 · NCI · NEW YORK UNIVERSITY · PI WILSON, E LYNETTE · 1989 to 1991
–
NCI NIH HHS CA 20194NCI NIH HHS CA 34282NCI NIH HHS CA 49419
6 · The paper itself

Abstract

Basic fibroblast growth factor (bFGF) is a potent mitogen for human bone marrow stromal cells and stimulates haematopoiesis in vitro. We report here that primary human bone marrow cultures contain bFGF and express heparin-like bFGF binding sites on the cell surface and in the extracellular matrix (ECM). bFGF bound predominantly to a 200-kD cell surface heparan sulfate proteoglycan (HSPG), which was also found in conditioned medium. bFGF was released from bone marrow cultures by incubation with phosphatidylinositol-specific phospholipase C (PI-PLC) and, less efficiently, by plasmin. Solubilized bFGF was found as a complex with the 200-kD HSPG. The complex was biologically active as shown by its ability to stimulate plasminogen activator production in bovine aortic endothelial cells. bFGF-HSPG complexes of bovine endothelial cells, however, were not released by PI-PLC. While only trace amounts of the bFGF-binding 200-kD HSPG were released spontaneously from bone marrow cultures, incubation with PI-PLC solubilized almost all of the 200-kD HSPG. The HSPG could be metabolically labeled with ethanolamine or palmitate, which was partially removed by treatment with PI-PLC. These findings indicate linkage of the HSPG to the cell surface via a phosphatidylinositol anchor. Plasmin released the 200-kD HSPG less efficiently than PI-PLC. We conclude that HSPGs of human bone marrow serve as a reservoir for bFGF, from which it can be released in a biologically active form via a dual mechanism; one involving a putative endogenous phospholipase, the other involving the proteolytic cascade of plasminogen activation.

Indexed as

AdultBone MarrowBone Marrow CellsCell MembraneCells, CulturedChondroitin Sulfate ProteoglycansFibrinolysinFibroblast Growth Factor 2Heparan SulfateHeparan Sulfate ProteoglycansHumansMolecular WeightPhosphatidylinositol Diacylglycerol-LyasePhosphoinositide Phospholipase CPhosphoric Diester HydrolasesPlasminogen ActivatorsChondroitin Sulfate ProteoglycansFibrinolysinFibroblast Growth Factor 2Heparan SulfateHeparan Sulfate ProteoglycansPhosphatidylinositol Diacylglycerol-LyasePhosphoinositide Phospholipase CPhosphoric Diester HydrolasesPlasminogen ActivatorsReceptors, Cell SurfaceReceptors, Fibroblast Growth Factor

Identifiers

PMID1654337
PMCPMC2289137
OpenAlexW2106008201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.